Yousef and Finger review results of clinical treatment of 101 squamous conjunctival and corneal tumors in 99 patients with at least 6 months (mean, 22 months) of follow-up. The median age of the group ...
Skin cancer, a prevalent and potentially life-threatening condition, affects millions of people worldwide. As advancements in medical science continue to evolve, so do the treatment options available ...
Case series showed 5% ointment may be safe and effective for diffuse conjunctival melanoma in situ or ocular surface squamous neoplasia. HealthDay News — Compounded imiquimod 5% ointment may be safe ...
First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA ...
Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing recurrence risk by 68% in the C-POST trial. Administered post-surgery and radiation ...
A multicenter retrospective review of 269 nail unit squamous cell carcinoma (NSCC) cases found that human papillomavirus (HPV)-related lesions were more often periungual and in situ, whereas subungual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results